Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 26, 2015 4:24 AM ET

Pharmaceuticals

Company Overview of CerRx Inc.

Company Overview

CerRx Inc. engages in the discovery and development of anticancer drugs for cancer patients. Its products include Fenretinide, a synthetic molecule that increases ceramide waxes and kills cancer cells; and Safingol, an artificial ceramide precursor that increases killing of fenretinide in cancer cells. The company was founded in 2008 and is based in Lubbock, Texas.

9801 Reese Boulevard

Suite 104

Lubbock, TX 79416

United States

Founded in 2008

Phone:

806-780-6068

Key Executives for CerRx Inc.

Chief Executive Officer
Age: 70
Chief Medical Officer
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Savara Inc. United States
Carmot Therapeutics, Inc. United States
Apertus Pharmaceuticals, LLC United States
Immunogenetics, Inc United States
Innovative Custom Products, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CerRx Inc., please visit www.cerrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.